FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R‑CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL

EHA Library, David Belada, 325256

EARLY RESPONSE AT ONE MONTH IS PREDICTIVE OF THE OUTCOME OF THE PATIENTS WITH RELAPSE/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CAR T-CELL

EHA Library, Jean Galtier, 325257

CD19 CAR-T IN LESS FIT PATIENTS WITH R/R HIGH-GRADE LYMPHOMA

EHA Library, Andrea Kuhnl, 325258

SUBCUTANEOUS EPCORITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA: SAFETY PROFILE AND ANTI-TUMOR ACTIVITY

EHA Library, Rogier Mous, 325259

PIRTOBRUTINIB (LOXO-305), A NEXT GENERATION, HIGHLY SELECTIVE, NON-COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED MCL, WM AND OTHER NHLS: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

EHA Library, Nirav N Shah, 325260

GLOFITAMAB STEP-UP DOSING (SUD): UPDATED EFFICACY DATA SHOW HIGH COMPLETE RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL) PATIENTS (PTS)

EHA Library, Carmelo Carlo-Stella, 325261

IBRUTINIB, BENDAMUSTINE, RITUXIMAB FOR RELAPSED AND REFRACTORY AGGRESSIVE B CELL LYMPHOMA – FINAL ANALYSIS OF PHASE II CLINICAL TRIAL

EHA Library, Meirav Kedmi, 325262

MOSUNETUZUMAB (MOSUN) MONOTHERAPY FOR ELDERLY/UNFIT PATIENTS (PTS) WITH FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) CONTINUES TO SHOW PROMISING SAFETY AND EFFICACY WITH DURABLE COMPLETE RESPONSES

EHA Library, Adam Olszewski, 325263

DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN PATIENTS OLDER THAN 65 YEARS: ANALYSIS OF 3 YEAR REAL WORLD DATA OF PRACTICE PATTERNS AND OUTCOMES IN ENGLAND

EHA Library, Toby Eyre, 325264

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH CONDITIONING INCLUDING ALLOGENEIC BISPECIFIC CAR-T CELLS TARGETING BOTH CD19 AND CD22 FOR REFRACTORY/RELAPSED B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Fan Yang, 325265

ECHELON-2, (NCT01777152), 5-YEAR RESULTS OF A RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY OF FRONTLINE BRENTUXIMAB VEDOTIN + CHP VS CHOP IN PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMA

EHA Library, Eva Domingo Domènech, 325266

RELAPSE AND SURVIVAL POST-PROGRESSION IN LYMPHOMA PATIENTS AFTER STEM CELL TRANSPLANTATION

EHA Library, Ayumi Fujimoto, 325267

CRS AND ICANS RISK ACROSS THREE CD19 CAR-T CELL PRODUCTS IN PATIENTS WITH AGGRESSIVE NHL

EHA Library, Jordan Gauthier, 325268

EFFICACY AND SAFETY OF MOGAMULIZUMAB BY PATIENT BLOOD CLASSIFICATION

EHA Library, Julia Scarisbrick, 325269

COMPARATIVE EFFICACY OF TISAGENLECLEUCEL (TISA-CEL) AND LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Marie José Kersten, 325270

PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULATORY THERAPY CRITERIA (LYRIC) IN GATA TRIAL FROM THE LYSA GROUP

EHA Library, Yassine Al Tabaa, 325271

INTRAVENOUS HIGH DOSE METHOTREXATE FOR PREVENTION OF CNS RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): REAL-WORLD OUTCOMES AND PRACTICE PATTERNS FROM CHINESE INSTITUTION

EHA Library, Qingqing Cai, 325272

COMPREHENSIVE GERIATRIC ASSESSMENT-DRIVEN TREATMENT DECISION VERSUS CLINICAL JUDGMENT IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA

EHA Library, Hui Liu, 325273

INFECTION-RELATED MORBIDITY AND MORTALITY FOR ELDERLY DLBCL PATIENTS TREATED WITH FULL OR ATTENUATED DOSE R-CHOP

EHA Library, Toby Eyre, 325274

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN KIDNEY TRANSPLANT PATIENTS: A MULTICENTER REPORT IDENTIFYING THE IMPORTANCE OF ALLOGRAFT PRESENTATION

EHA Library, Elise Chong, 325275

SAFETY AND EFFICACY OF TISAGENLECLEUCEL PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: UPDATED ANALYSIS OF THE PHASE 1B PORTIA STUDY

EHA Library, Ulrich Jäger, 325276

INTERIM-PET IS NOT PREDICTIVE OF OUTCOME IN DLBCL PATIENTS WITH MYC REARRANGEMENTS DUE TO ABERRANT RESPONSE PATTERNS

EHA Library, Jakoba J. Eertink, 325277

DURATION OF RESPONSE TO LONCASTUXIMAB TESIRINE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS: SUBGROUP ANALYSES FROM LOTIS-2

EHA Library, Paolo F. Caimi, 325278

PROGNOSTIC SIGNIFICANCE OF TIME FROM LAST THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS AND CLAIMS DATA IN THE US

EHA Library, Michael Dickinson, 325279

PROGNOSIS AND HEPATIC TOXICITY IN HEPATITIS C VIRUS-POSITIVE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Minyue Zhang, 325280

BASELINE TOTAL METABOLIC TUMOR VOLUME >220CM³ AND DEAUVILLE 5-POINT SCALE OF ≥4 AFTER FOUR CYCLES OF R-CHOP ARE STRONGLY ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL IN PATIENTS WITH DLBCL

EHA Library, Eduard Schulz, 325281

THE IMPACT OF THE GERIATRIC 8 SCORE ON OVERALL SURVIVAL IN OLDER ADULTS WITH DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Kana Oiwa, 325282

DOES INTENSIVE CHEMOTHERAPY REALLY HELP OLDER DLBCL PATIENTS LIVE LONGER?

EHA Library, Dominic Gordon-Walker, 325283

PIRTOBRUTINIB (LOXO-305), A NEXT GENERATION, HIGHLY SELECTIVE, NON-COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED RICHTER TRANSFORMATION: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

EHA Library, Anthony R. Mato, 325284

PRELIMINARY SAFETY DATA FROM PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES TREATED WITH THE NOVEL B-CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB-11417

EHA Library, Chan Cheah, 325285

PATIENTS WITH OUT OF SPECIFICATION TISAGENLECLEUCEL CAN BE SALVAGED WITH POINT-OF-CARE CAR-T CELLS: AN OBSERVATIONAL INTENTION-TO-TREAT SINGLE-CENTER ANALYSIS

EHA Library, Shalev Fried, 325286

DISCOVERY OF HBW-3-20, THE FIRST REVERSIBLE INHIBITOR OF BRUTON’S TYROSINE KINASE (BTK) WITH HIGH BRAIN EXPOSURE

EHA Library, Chester Yuan, 325287

CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WHO RECEIVED ≥3 LINES OF THERAPIES

EHA Library, Laura Liao, 325288

REAL WORLD CLINICAL EFFECTIVENESS AND SAFETY OF CT-P10 IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST AUTHORIZATION SAFETY STUDY

EHA Library, Pier Luigi Zinzani, 325289

LYMPHOCYTE COUNT EFFECT ON EFFICACY AND SAFETY OF SINGLE AGENT ORAL SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POST-HOC ANALYSIS FROM PHASE 2B SADAL STUDY

EHA Library, Michael Schuster, 325290

CLINICOPATHOLOGIC DESCRIPTORS OF MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): ANALYSIS OF A POOLED DATABASE OF A NEW ENTITY

EHA Library, Philip Haddad, 325291

POPULATION-BASED COHORT STUDY OF THE EFFICACY OF BRENTUXIMAB-VEDOTIN IN RELAPSED SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA USING PUBLIC HEALTH ENGLAND DATA

EHA Library, Sarah Halligan, 325292

COMBINED TREATMENT OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS TRANSPLANTATION WITH CAR T-CELL THERAPY IMPROVES OUTCOMES IN MANAGEMENT OF ADVANCED RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM B-CELL LYMPHOMA

EHA Library, Kai Hu, 325293

LENALIDOMIDE AND RITUXIMAB REGIMEN COMBINED WITH INTRAVITREAL METHOTREXATE FOLLOWED BY LENALIDOMIDE MAINTENANCE FOR PRIMARY VITREORETINAL LYMPHOMA: A PROSPECTIVE PHASE II STUDY

EHA Library, Yan Zhang, 325294

BASELINE TUMOR BURDEN CORRELATES WITH RESPONSE BUT NOT TOXICITIES IN PATIENTS TREATED WITH BISPECIFIC ANTI-CD20, ANTI-CD19 CAR-T CELLS

EHA Library, Joanna Zurko, 325295

IMPACT OF TP53 AND RECURRENT SOMATIC MUTATIONS ON THE OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR-T)

EHA Library, Vania Phuoc, 325296

CHIDAMIDE PLUS CHOP VERSUS CHOP AS FRONTLINE TREATMENT IN PERIPHERAL T CELL LYMPHOMA: A RETROSPECTIVE CASE-CONTROL STUDY

EHA Library, Qingqing Cai, 325297

HIGH PREVALENCE OF CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY IN A PEDIATRIC T-CELL LYMPHOBLASTIC LYMPHOMA COHORT

EHA Library, Emma Kroeze, 325298

CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA RECEIVING CONVENTIONAL THIRD-LINE THERAPY: A MULTICENTER, RETROSPECTIVE, REAL-WORLD STUDY IN THE UNITED KINGDOM

EHA Library, Christopher Fox, 325299

EARLY GCSF AFTER ANTI-CD19 CAR T-CELLS DECREASES INCIDENCE OF FEBRILE NEUTROPENIA WITHOUT WORSENING TOXICITIES AND EXPANSION OF CAR T-CELLS IN REFRACTORY/RELAPSED B-CELL LYMPHOMA.

EHA Library, Raphael Lievin, 325300

OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE NONUNIVERSITY SETTING

EHA Library, John Godwin, 325301

CONCURRENT GAIN/AMPLIFICATION OF MYC, BCL2 AND/OR BCL6 GENES BY FLUORESCENCE IN SITU HYBRIDIZATION: ANOTHER SUBGROUP OF HIGH-GRADE B-CELL LYMPHOMA WITH POOR PROGNOSIS?

EHA Library, Siska Blomme, 325302

VENETOCLAX AS SINGLE AGENT IN BCL2-POSITIVE RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS. A PHASE 2 STUDY OF THE FONDAZIONE ITALIANA LINFOMI.

EHA Library, Francesco Zaja, 325303

POLATUZUMAB VEDOTIN IN COMBINATION WITH BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA: INTERIM ANALYSIS.

EHA Library, Olesia Smykova, 325304

RATIONALE FOR TREATMENT SELECTION, AND COMORBIDITIES IN OLDER PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): INSIGHTS FROM REAL WORLD DATA (RWD)

EHA Library, Ashwini Shewade, 325305

VALIDATION OF THE BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL-IPI) IN PATIENTS FROM TWO CHEMOIMMUNOTHERAPY TRIALS (BURKIMAB-08 AND BURKIMAB-14) BY THE PETHEMA AND GELTAMO GROUPS

EHA Library, Josep Maria Ribera, 325306

EXTRANODAL DISEASE IS AN INDEPENDENT NEGATIVE PREDICTIVE MARKER FOR PROGRESSION-FREE SURVIVAL AFTER CD19-CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Veit Bücklein, 325307

ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE TREATMENT FOR DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Huayuan Zhu, 325308

COMPARISON OF CHIDAMIDE-CONTAINED TREATMENT MODALITIES VERSUS CHEMOTHERAPY IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Qingqing Cai, 325309

CELL OF ORIGIN IMPACTS DELTASUVMAX CUTOFF FOR PREDICTION OF RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Carolina Feres, 325310

COMPARISON OF IMMUNOCHEMOTHERAPY WITH RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) OR RITUXIMAB-CHOP (R-CHOP) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)

EHA Library, Theodoros Vassilakopoulos, 325311

PREDICTIVE VALUE OF INTERIM FDG-PET/CT SCAN IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Veronika Hanáčková, 325312

ESTIMATION OF LONG-TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Dan Huang, 325313

SAFETY OF AMBULATORY HIGH-DOSE METHOTREXATE (HDMTX) ADMINISTRATION AMONG HEMATOLOGICAL MALIGNANCIES PATIENTS IN TERTIARY CARE CENTER

EHA Library, Maged AL-AMMARI, 325314

OUTCOME OF RITUXIMAB-POLATUZUMAB-BENDAMUSTINE IN THE TREATMENT OF RELAPSED/ REFRACTORY HIGH GRADE LYMPHOMA AND TRANSFORMED HIGH GRADE LYMPHOMA – A MULTI-CENTRE ANALYSIS.

EHA Library, Lydia Sodhi, 325315

TREATMENT EFFICACY AND OUTCOMES OF RARE HIV-RELATED PLASMABLASTIC LYMPHOMA: THE RESULTS OF MULTICENTER RETROSPECTIVE STUDY IN RUSSIA

EHA Library, Marina Popova, 325316

ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA TREATED BY DA-EPOCH-R AND R-CHOP

EHA Library, Yana Stepanishyna, 325317

VALUE OF MICROSATELLITE INSTABILITY MARKERS IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA DIAGNOSTICS

EHA Library, Natalya Risinskaya, 325318

DIAGNOSTIC YIELD AND SAFETY OF IMAGE-GUIDED PERCUTANEOUS SPLENIC BIOPSY – A TWO-CENTRE EXPERIENCE FROM THE EAST OF ENGLAND

EHA Library, Francis Anyanwu, 325319

IDENTIFYING THE INTRAVASCULAR LARGE B-CELL LYMPHOMA BY FDG PET/CT IMAGING: A SINGLE-CENTER, MATCHED CASE-CONTROL STUDY

EHA Library, Shenmiao Yang, 325320

GLOMERULAR FILTRATION RATE (GFR) IS AN INDEPENDENT PROGNOSTIC FACTOR AFFECTING SURVIVAL OF PATIENTS WITH B-LARGE CELL LYMPHOMAS (B-LCL)

EHA Library, Igor Aurer, 325321

A NOVEL LIPID-COVERED PROGNOSTIC SCORING MODEL FOR NEWLY DIAGNOSED MATURE T AND NK CELL LYMPHOMAS

EHA Library, Tiange Lu, 325322

UTILITY OF PROGNOSTIC INDICES IN DIFFUSE LARGE B-CELL LYMPHOMA FOR THE DETECTION OF HIGH RISK PATIENTS.

EHA Library, Patricia López-Menargues, 325323

MODIFIED R-BFM IMMUNOCHEMOTHERPY RESULTS HIGHER FREQUENCY OF COMPLETE REMISSION THAN R-DA-EPOCH/R-CHOP IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA DOUBLE-HIT TRANSFORMED FROM FOLLICULAR LYMPHOMA.

EHA Library, Anna Misyurina, 325324

DEVELOPMENT AND VALIDATION OF A PROGNOSTIC NOMOGRAM FOR PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Hua Wang, 325325

EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: ADVANCE SC, A GLOBAL PHASE 3 CLINICAL TRIAL IN PROGRESS

EHA Library, Vickie McDonald, 325326

PERI-OPERATIVE PK-GUIDED DOSING OF DESMOPRESSIN COMBINED WITH FVIII CONCENTRATES IN HEMOPHILIA A: FINAL RESULTS OF THE DAVID STUDY

EHA Library, Lorenzo Romano, 325327

APPLICATION OF THROMBOELASTOGRAPHIC MARKERS TO PREDICT THE SURVIVAL IN ACUTE TRAUMA PATIENTS.

EHA Library, Hyunjung Kim, 325328

POPULATION PHARMACOKINETIC MODELING OF FACTOR CONCENTRATES IN HEMOPHILIA: A DETAILED OVERVIEW FOR CLINICIANS AND EVALUATION OF OUR BEST PRACTICE.

EHA Library, Tine Goedhart, 325329

FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A GENOTYPE TO PHENOTYPE CORRELATION AND ANALYSIS

EHA Library, Guilherme Sacchi de Camargo Correia, 325330

ACQUIRED VON WILLEBRAND DISEASE: THE DIAGNOSIS AND MANAGEMENT OF AN UNDERDIAGNOSED COAGULOPATHY

EHA Library, antonietta ferretti, 325331

INVESTIGATION OF PRETERM INTRAVENTRICULAR HEMORRHAGE-INDUCED INFLAMMATORY RESPONSE AND MICRORNA LEVELS IN HUMAN CHOROID PLEXUS EPITHELIAL CELLS

EHA Library, Fejes Zsolt, 325332

THE ANALYSIS OF THE TREATMENT OUTCOME OF PATIENTS WITH ACQUIRED HEMOPHILIA IN CROATIA

EHA Library, Marijo Vodanovic, 325333

HAEMOPHILIA B LEYDEN, AN AGE-RELATED MECHANISM FOR AN INCREASE OF FACTOR IX: CASE REPORT AND LITERATURE REVIEW

EHA Library, Cristina Alburquerque-Prieto, 325334

HEMOPHILIA A SELF-MANAGEMENT – PATIENTS’ PERSPECTIVES AND CHALLENGES

EHA Library, Irena Preložnik Zupan, 325335

CONGENITAL COMBINED VITAMIN K-DEPENDENT CLOTTING FACTORS DEFICIENCY, CASE REPORTS

EHA Library, Dmitry Florinskiy, 325336

IS ANTI-NUCLEAR ANTIBODY POSITIVITY A FACTOR FOR AFFECTING TREATMENT RESPONSE IN IMMUNE THROMBOCYTOPENIA PATIENTS ON ELTROMBOPAG?

EHA Library, Mehmet Baysal, 325337

NEW LIKELY PATHOGENIC VARIANTS IN THREE SPANISH PATIENTS WITH MILD HEMOPHILIA A AND B: GENETIC COUNSELING.

EHA Library, Maria Civeira, 325338

BEVACIZUMAB AND RESCUE TREATMENT FOR SEVERE GASTROINTESTINAL BLEEDING IN VON WILLEBRAND DISEASE

EHA Library, D. Rochate, 325339

ANTI-COX-2 AUTOANTIBODY AS A NOVEL DIAGNOSTIC MARKER IN APLASTIC ANEMIA

EHA Library, Tiina Kelkka, 325340

COMPARISON OF LYMPHOCYTE SUBSETS IN HYPOPLASTIC MYELODYSPLASTIC SYNDROMES AND APLASTIC ANEMIA

EHA Library, Meili Ge, 325341

DRIED BLOOD SPOT METABOLOMICS REVEALS A METABOLIC FINGERPRINT WITH DIAGNOSTIC POTENTIAL FOR DIAMOND BLACKFAN ANEMIA

EHA Library, Birgit Van Dooijeweert, 325342

A PIGA CONDITIONAL KNOCK-OUT MOUSE MODEL MEDIATED BY VAV-ICRE: STABLE GLYCOSYLPHOSPHATIDYLINOSITOL-DEFICIENT AND MILD HEMOLYSIS

EHA Library, Yingying Chen, 325343

CYTOKINE-PRODUCING ABILITY OF MESENCHYMAL CELLS OF THE BONE MARROW STROMA IN CASE OF NEUTROPENIA IN CHILDREN

EHA Library, Konstantin Vetoshkin, 325344

BCX9930, A NOVEL ORAL FACTOR D INHIBITOR, HAS POSITIVE EFFECTS ON HEMOLYSIS AND CLINICAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) NAÏVE TO COMPLEMENT INHIBITORS

EHA Library, Andrew McDonald, 325345

RAVULIZUMAB ADMINISTERED SUBCUTANEOUSLY VERSUS INTRAVENOUSLY IN ADULT PATIENTS WITH PNH PREVIOUSLY TREATED WITH ECULIZUMAB: RESULTS FROM A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY

EHA Library, Mustafa N. Yenerel, 325346

LONG-TERM FOLLOW UP AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR IDIOPATHIC SEVERE APLASTIC ANEMIA. THE EXPERIENCE OF THE SPANISH GROUP OF HEMATOPOIETIC STEM CELL TRANSPLANT (GETH).

EHA Library, Lucrecia Yanez, 325347

LONGITUDINAL CLINICAL AND LABORATORY DATA AND OUTCOME OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA

EHA Library, Stavros Papadakis, 325348

BCX9930, AN ORAL FACTOR D INHIBITOR, CONTROLS EXTRAVASCULAR HEMOLYSIS AND ALLEVIATES ASSOCIATED SYMPTOMS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS

EHA Library, Austin Kulasekararaj, 325349

PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF RAVULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: INTERIM ANALYSIS OF A PHASE 3, OPEN-LABEL STUDY

EHA Library, Satheesh Chonat, 325350

REAL - WORLD SCENARIO OF RESPONSE WITH LONG - TERM USE OF ANDROGENIC STEROIDS IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA: REPORT FROM A TERTIARY CARE HOSPITAL IN WEST BENGAL, INDIA

EHA Library, Ankita Sen, 325351

MANAGEMENT OF MENINGOCOCCAL DISEASE RISK IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON COMPLEMENT INHIBITORS: 18 YEARS’ EXPERIENCE FROM THE UK NATIONAL PNH SERVICE IN LEEDS

EHA Library, Louise Arnold, 325352

ELTROMBOPAG PLUS IMMUNOSUPPRESSIVE THERAPY VERSUS MATCHED SIBLING DONOR TRANSPLANTATION AS FIRST-LINE THERAPY FOR SEVERE APLASTIC ANEMIA – A META-ANALYSIS

EHA Library, Jiang Ji, 325353

SAFETY OF RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: STUDY 301/302 2-YEAR RESULTS

EHA Library, Regis Peffault De La Tour, 325354

EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: WEEK 48 OF PEGASUS PHASE 3 TRIAL COMPARING PEGCETACOPLAN TO ECULIZUMAB

EHA Library, Alexander Röth, 325355